First reports from CROI: the cure, new drugs, kids, PrEP and hepC
5 April 2012. Related: News.
The Conference of Retroviruses and Opportunistic Infections (CROI) is the most important annual HIV conference.
Our first reports are mow published in HIV Treatment Bulletin (HTB) online and in print.
Exciting and important new breakthroughs including for: cure research, pipeline drug. children’s studies including new formulations, PrEP: close to 100% protection? HIV reinfection and new hepatitis C drugs.
Much of the conference is available as web casts and references in HTB also link to the study abstracts. Further coverage will continue in the next issue, with pre-press articles available online.
- PrEP: PK modeling of daily TDF/FTC (Truvada) provides close to 100% protection against HIV infection
- High dose flu vaccine improves antibody responses in HIV positive people